Yup... new investor should realize that they are invested in the company that has developed the cure for 2 of deadliest plagues known to mankind. ALL CANCERS and CORONAVIRUS 19-30
$$NOW WE HAVE FUNDING $$
Their cancer drug has been developed over 10years of Vitro, preclinical and all xenograft trials including mice growing human cancer.. Now ready for Human clinical trials. Now that we have a funding partnership SBFM is going to take off big!!!
“Adva-27a is the only compound known that is capable of destroying Multidrug Resistant Cancer Cells.“
Adva-27a Anticancer Drug
Since inception, Sunshine Biopharma has been involved in the development of Adva-27a, a small molecule that has been shown to be exceptionally effective at destroying Multidrug Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5).
These and other preclinical results have been published in ANTICANCER RESEARCH, Volume 32, Pages 4423-4432, October 2012. Adva-27a is the only compound known that is capable of destroying Multidrug Resistant Cancer Cells. The Company is planning to conduct Adva-27a Phase I Clinical Trials for Pancreatic Cancer indication at McGill University’s Jewish General Hospital in Montreal (Canada).
Sunshine Biopharma is a direct owner of all worldwide patents covering Adva-27a, including all issued and pending patents under PCT/FR2007/000697 and PCT/CA2014/000029.
